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Abstract
Background: Policy has a tremendous potential to improve population health when informed by research evidence.
Such evidence, however, typically plays a suboptimal role in policymaking processes. The field of policy dissemination and
implementation research (policy D&I) exists to address this challenge. The purpose of this study was to: (1) determine the
extent to which policy D&I was funded by the National Institutes of Health (NIH), (2) identify trends in NIH-funded policy
D&I, and (3) describe characteristics of NIH-funded policy D&I projects.
Methods: The NIH Research Portfolio Online Reporting Tool was used to identify all projects funded through D&I-focused
funding announcements. We screened for policy D&I projects by searching project title, abstract, and term fields for
mentions of “policy,” “policies,” “law,” “legal,” “legislation,” “ordinance,” “statute,” “regulation,” “regulatory,” “code,” or “rule.”
A project was classified as policy D&I if it explicitly proposed to conduct research about the content of a policy, the
process through which it was developed, or outcomes it produced. A coding guide was iteratively developed, and all
projects were independently coded by two researchers. ClinicalTrials.gov and PubMed were used to obtain additional
project information and validate coding decisions. Descriptive statistics—stratified by funding mechanism, Institute, and
project characteristics—were produced.
Results: Between 2007 and 2014, 146 projects were funded through the D&I funding announcements, 12 (8.2 %) of
which were policy D&I. Policy D&I funding totaled $16,177,250, equivalent to 10.5 % of all funding through the D&I
funding announcements. The proportion of funding for policy D&I projects ranged from 14.6 % in 2007 to 8.0 % in
2012. Policy D&I projects were primarily focused on policy outcomes (66.7 %), implementation (41.7 %), state-level
policies (41.7 %), and policies within the USA (83.3 %). Tobacco (33.3 %) and cancer (25.0 %) control were the primary
topics of focus. Many projects combined survey (58.3 %) and interview (33.3 %) methods with analysis of archival data
sources.
Conclusions: NIH has made an initial investment in policy D&I research, but the level of support has varied between
Institutes. Policy D&I researchers have utilized a variety of designs, methods, and data sources to investigate the
development processes, content, and outcomes of public and private policies.
Background
Policy has a tremendous potential to improve population
health [1, 2]. The extent to which policy produces such
outcomes, however, often depends upon the degree to
which it is informed by scientific knowledge and aligned
with evidence-based interventions [3–5]. Unfortunately,
research typically plays a minor role in policymaking
processes [6, 7]. For decades, scholars have documented
myriad barriers to translating research into policy—in-
cluding political influences, economic constraints, scien-
tific uncertainty, and institutional culture [8–20].
The field of health policy dissemination and imple-
mentation research (policy D&I) exists to address these
challenges. Policy D&I is focused on generating know-
ledge to effectively spread research evidence among pol-
icymakers and integrate evidence-based interventions
into policy designs [5]. Policy D&I, known as policy
“knowledge translation and exchange” outside of the
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USA, has evolved over the past 40 years. The 1970s and
1980s were marked by interest in how social science re-
search was used in public policymaking and saw the de-
velopment of key contributions to the field—such as
Weiss’ typology of research evidence [7] and Caplan’s
two communities theory of knowledge utilization [17].
In the 1990s and 2000s, frameworks and instruments for
policy D&I emerged [21–25] and the field was embraced
within the discipline of public health [9, 26, 27]. Today,
policy D&I is a priority of the World Health Organization
[28, 29] and a major focus of journals such as Health Re-
search Policy and Systems and Evidence & Policy.
The history of policy D&I has demonstrated that gov-
ernment funding is essential for a county to develop and
maintain a robust policy D&I research infrastructure
[22, 30]. Outside of the USA, governments have made
sustained investments in policy D&I research and initia-
tives to promote the use of research evidence in health
policymaking. Examples include the Canadian Institutes
of Health Research’s integrated knowledge translation
programs, the National Health and Medical Research
Council of Australia’s Partnership Projects and Centres,
and the UK National Institute for Health Research’s Col-
laboration for Leadership in Applied Health Research
and Care. While national governments have invested in
policy D&I abroad, policy D&I research has largely
existed outside of the mainstream, government-funded
health research enterprise in the USA [6]. This is poten-
tially changing, however, as the National Institutes of
Health (NIH)—the largest government funder of health
research in the USA—has recently invested in the
broader field of D&I research and identified policy D&I
as a priority [31].
In 2002, the National Institute of Mental Health issued
a Program Announcement (PAR) entitled “Dissemin-
ation and Implementation Research in Mental Health”
that highlighted the importance of developing effective
strategies to disseminate research findings to the policy-
makers [32]. In 2005, the PAR was re-issued under the
broader name “Dissemination and Implementation
Research in Health” (D&IRH) with more participating
Institutes (e.g., the National Cancer Institute, National
Institute on Drug Abuse) [33]. In 2007, the NIH Center
for Scientific Review created a permanent D&IRH study
section to evaluate D&I proposals, re-affirming NIH’s in-
vestment in the field [34]. In 2013, the “D&IRH” PAR
was re-issued, this time with a greater emphasis on pol-
icy D&I research [35]. For example, the PAR encouraged
applications that “address[ed] the complexity of bridging
research, policy and practice.”
NIH has expressed interest in policy D&I research, but
the extent to which it has funded research in this area is
unclear. Two recent studies reviewed NIH D&I funding
related to specific topics; one study focused on nursing
Fig. 1 Flow diagram summarizing the process used to identify policy D&I research projects funded by NIH, federal fiscal years 2007–2014. NIH
National Institutes of Health, D&I dissemination and implementation, FOAs funding opportunity announcements
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[36] and the other focused on cancer control [37]. A
similar review of policy D&I research is needed to assess
growth of the field and identify funding gaps. Such a
study would support growth in the field of policy D&I in
the USA by providing investigators with a menu of ap-
proaches to policy D&I research that can be adopted
and adapted when developing proposals. This article re-
ports the results of a study that was conducted to ad-
dress these knowledge gaps. The aims of the study were
to: (1) determine the extent to which policy D&I re-
search has been funded by NIH between 2007 and 2014,
(2) identify trends in NIH-funded policy D&I research,
and (3) describe the characteristics of NIH-funded policy
D&I research projects.
Methods
We used the NIH Research Portfolio Online Reporting
Tool [38] to identify all projects that received funding
during any US fiscal year between 2007 and 2014
through the D&I funding opportunity announcements
(FOAs) Dissemination and Implementation Research in
Health (PARs: 06-039, 06-071, 06-072, 06-520, 06-521,
07-086, 10-038, 10-039, 10-040, 13-054, 13-055, 13-056)
or Dissemination and Implementation Research in
Mental Health (PA 02-131). We selected 2007 as the
starting point because it was the first year that projects
supported by the Dissemination and Implementation
Research in Health FOAs received funding. For each
project, we extracted the title, abstract, project terms,
Table 1 NIH-funded policy D&I research projects by funding mechanism, Institute, and percentage of all research funded through
D&I FOAs, federal fiscal years 2007–2014
Funding
source
Number of projects funded through
D&I FOAs
Amount funded through D&I
FOAs (%)a
Number of policy D&I projects
funded (%)b
Amount funded for policy of
D&I (%)b
Total
146 $154,339,271 (0.09) 12 (8.2) $16,177,250 (10.5)
Funding mechanism
R01 82 $134,439,725 (0.19) 7 (8.5) $14,626,930 (10.9)
R03 12 $1,745,967 (0.25) 1 (8.3) $150,000 (8.6)
R21 51 $18,042,301 (0.36) 4 (7.8) $1,400,320 (7.8)
R34 1 $111,278 (0.03) 0 (0) $0 (0)
Institute
NCI 46 $47,631,105 (0.19) 6 (13.0) $5,993,592 (12.6)
NIMH 40 $51,237,349 (0.57) 3 (7.5) $4,328,310 (8.4)
NIAID 18 $13,093,827 (0.06) 1 (5.6) $320,720 (2.4)
NIDA 12 $11,691,400 (0.19) 1 (8.3) $1,872,963 (16.0)
NHLBI 8 $12,248,387 (0.07) 1 (12.5) $3,393,577 (27.7)
NINR 7 $8,983,908 (1.03) 0 (0) $0 (0)
FIC 4 $667,849 (0.29) 0 (0) $0 (0)
OD 3 $384,426 (0.02) 1 (33.3) $268,088 (69.7)
NIDCR 3 $2,538,584 (0.11) 0 (0) $0 (0)
NCCAM 2 $864,887 (0.17) 0 (0) $0 (0)
NIDCD 2 $352,052 (0.01) 0 (0) $0 (0)
NINDS 1 $2,601,603 (0.02) 0 (0) $0 (0)
NIDDK 1 $1,396,497 (0.01) 0 (0) $0 (0)
NIAAA 1 $408,039 (0.02) 0 (0) $0 (0)
NIA 1 $239,358 (0.00) 0 (0) $0 (0)
NIH National Institutes of Health, NCI National Cancer Institute, NIMH National Institute of Mental Health, NIDA National Institute on Drug Abuse, NHLBI National
Heart, Lung, and Blood Institute, OD NIH Office of the Director, NIAID National Institute of Allergy and Infectious Diseases, NINR National Institute of Nursing
Research, FIC Fogarty International Center, NIDCR National Institute of Dental and Craniofacial Research, NCCAM National Center for Complementary and
Alternative Medicine, NIDCD National Institute on Deafness and Other Communication Disorders, NINDS National Institute of Neurological Disorders and Stroke,
NIDDK National Institute of Diabetes and Digestive and Kidney Diseases, NIAAA National Institute on Alcohol Abuse and Alcoholism, NIA National Institute on
Aging, D&I dissemination and implementation, FOAs funding opportunity announcements
aPercentages indicating the proportion of D&I funding within total NIH research grant spending category (e.g., proportion of research grant funding for R01
projects that were for D&I projects, $134,439,725/$71,808,892,375 = 0.19 %). Total research grant amounts for each NIH spending category are not shown.
Source: https://report.nih.gov/fundingfacts/fundingfacts.aspx
bPercentages indicating the proportion of policy D&I within total D&I category (e.g., proportion of R01 projects funded through D&I FOAs that were policy D&I
projects, 7/82 = 8.5 %)
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award amount per fiscal year, funding mechanism, and
Institute.
Our review was guided by Bogenschneider’s definition
of policy as: “the development, enactment, and imple-
mentation of a plan or course of action carried out
through law, rule, code, or other mechanism in the pub-
lic or private sector” [5]. Accordingly, we identified po-
tential policy D&I projects by searching the project title,
abstract, and term fields for mentions of “policy,” “pol-
icies,” “law,” “legal,” “legislation,” “ordinance,” “statute,”
“regulation,” “regulatory,” “code,” or “rule.” Two coders
then independently reviewed project abstracts and devel-
oped preliminary coding categories to capture project
characteristics. These categories reflected themes in that
data, categories used in previous NIH D&I funding re-
views [36, 37], and policy D&I scholarship [3–6, 8, 9].
The coders then jointly developed a coding guide and in-
dependently re-reviewed and coded the projects. Because
many projects were not exclusively focused on policy D&I,
projects were coded according to their policy D&I fea-
tures. Incongruent coding decisions were identified in
<10 % of projects and resolved through discussions.
We classified a project as policy D&I if it explicitly
proposed to conduct empirical research about the “con-
tent” of a policy (e.g., analysis of the text of clean indoor
air laws), the “process” through which it was developed
(e.g., assessment of how state legislators use research
evidence when developing clean indoor air laws), or the
“outcomes” it produced (e.g., evaluation of the impacts
of clean indoor air laws on cardiovascular health out-
comes). These inclusion criteria were informed by
Bogenschneider’s definition of policy [6] and domains of
health policy research proposed by Brownson and col-
leagues [3–5]. For projects classified as policy D&I, we
searched for its NIH project number in ClinicalTrials.-
gov [39] and PubMed [40] to obtain additional informa-
tion and validate coding decisions.
We calculated the total dollar amount awarded
through all NIH research grants and through the D&I
FOAs, stratified by funding mechanism and Institute.
We also calculated the amount awarded for policy D&I
projects, and the percentage of total D&I FOA funding
they comprised, within strata. Data were managed and
analyzed in Microsoft Excel.
Results and discussion
Between 2007 and 2014, 146 projects were funded
through the D&I FOAs, 12 (8.2 %) of which were classified
as policy D&I research (Fig. 1). A total of $16,177,250 was
awarded for these projects, equivalent to 10.5 % of all
funding through the D&I FOAs (Table 1). The NIH Office
of the Director allocated 69.7 % of its D&I FOA funding
to a policy D&I project, indicating agency-level support
for the field. The National Cancer Institute (NCI) was the
primary funder of policy D&I research, supporting six pro-
jects which comprised 13.0 % of all NCI funding through
the D&I FOAs. Some Institutes that were engaged in D&I
funding—such as the National Institute of Nursing Re-
search which funded seven D&I projects comprising over
1.0 % of the Institute’s total research grant spending, a
proportion larger than any other Institute—did not fund
any policy D&I projects. Differences in policy D&I funding
between Institutes could potentially be a reflection of
varying levels of knowledge about policy D&I research
among investigators within different health science disci-
plines or differences in the degree to which the disciplines
are clinically, as opposed to policy, oriented.
Fig. 2 Annual trends in NIH funding for D&I research, federal fiscal years 2007–2014. “Policy D&I funding” and “all D&I FOA funding” in millions, “all NIH
research grant funding” in billions, US dollars. NIH National Institutes of Health, D&I dissemination and implementation, FOAs funding
opportunity announcements
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NIH funding for policy D&I increased between 2007
and 2014 (Fig. 2). Annual policy D&I funding increased
by 98.9 % within this period, from $1,584,327 in 2007 to
$3,151,286 in 2014. The proportion of funding awarded
through the D&I FOAs that was for policy D&I projects
ranged from 14.6 % in 2007 to 8.0 % in 2011. Between
2012 and 2013, funding decreased by 6.3 % for all NIH
research grants and increased by 7.4 % for projects
funded through the D&I FOAs and by 51.8 % for policy
D&I projects.
NIH-funded policy D&I projects utilized a range of
methodologies and data sources across different domains
of policy research (Tables 2, 3, Additional file 1). These
projects were primarily focused on policy outcomes
(66.7 %), implementation research (41.7 %), state-level pol-
icies (41.7 %), and the USA (83.3 %). Tobacco (33.3 %)
and cancer control (25.0 %), for which evidence-based pol-
icy strategies exist [41, 42], were the most common topics
of focus. Many projects combined survey (58.3 %) and
interview (33.3 %) methods with analysis of archival data
sources, such as medical records (25.0 %) and policy docu-
ments (25.0 %). It was unclear; however, the extent to
which projects used true mixed-method designs (e.g., the
results of one method informed data collection of the
other, or the results of both methods were presented
together).
Limitations
We limited our review to projects funded through FOAs
explicitly focused on D&I and may not have identified all
NIH-funded policy D&I projects. Our review also did not
capture policy D&I projects funded by other US govern-
ment agencies or philanthropies. We did not attempt to ob-
tain the full text of proposals and thus did not have
complete information on project characteristics, such as in-
formation on how the projects planned to disseminate their
findings. We also did not have data on the characteristics of
policy D&I research proposals that were unsuccessful in
obtaining funding through NIH. Thus, we were unable to
identify specific characteristics that increased the likelihood
of a policy D&I project being funded. We dichotomously
Table 2 NIH-funded policy D&I research projects by study
characteristics, federal fiscal years 2007–2014
Study characteristics Number of policy
D&I projects (%)a
(N = 12)
Domain of policy research
Outcome 8 (66.7 %)
Process 5 (41.7 %)
Content 1 (8.3 %)
Type of policy
Public (e.g., laws, regulations) 6 (50.0 %)
Heath care financing/reimbursement 3 (25.0 %)
Workplace 2 (16.7 %)
Clinical practice 1 (8.3 %)
Level of policy
State 5 (41.7 %)
Local 3 (25.0 %)
Organization 3 (25.0 %)
National 1 (8.3 %)
Region of research focus
USA 10 (83.3 %)
Outside of USA 2 (16.7 %)
Health issue
Tobacco 4 (33.3 %)
Cancer 3 (25.0 %)
Drug abuse 2 (16.7 %)
Mental health 2 (16.7 %)
Child welfare 2 (16.7 %)
Implementation science objectives
Implementation 5 (41.7 %)
Dissemination 4 (33.3 %)
Adoption 2 (16.7 %)
Sustainability 1 (8.3 %)
Study design
Quasi-experimental 5 (41.7 %)
Non-experimental 4 (33.3 %)
Experimental 3 (25.0 %)
Methods used
Quantitative, surveys 7 (58.3 %)
Qualitative, interviews 4 (33.3 %)
Quantitative, medical record review 3 (25.0 %)
Content analysis, document analysis 3 (25.0 %)
Qualitative, focus groups 1 (8.3 %)
Quantitative, agent-based modeling 1 (8.3 %)
Content analysis, media analysis 1 (8.3 %)
Data source
Policymakers 3 (25.0 %)
Table 2 NIH-funded policy D&I research projects by study
characteristics, federal fiscal years 2007–2014 (Continued)
Policy documents 3 (25.0 %)
Healthcare providers 3 (25.0 %)
Administrative documents 3 (25.0 %)
Medical records 3 (25.0 %)
Community stakeholders 2 (16.7 %)
Media coverage 1 (8.3 %)
Unknown 1 (8.3 %)
NIH National Institutes of Health, D&I dissemination and implementation
aSome percentages exceed 100 because categories were not mutually exclusive
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categorized projects as policy D&I (yes/no) and did not dif-
ferentiate between projects in which policy D&I was the
primary focus or subcomponent. Because only 12 policy
D&I projects were identified, subgroup differences and
comparisons should be interpreted with caution.
Conclusions
NIH has made an initial investment in policy D&I research,
signaling that the field might be entering the mainstream
US health research enterprise. The level of support for pol-
icy D&I research, however, has varied between Institutes
and is probably not commensurate with the potential of
evidence-based policy to positively impact human health.
Policy D&I researchers have utilized a variety of designs,
methods, and data sources to investigate the development
processes, content, and outcomes of public and private
policies. By mapping the characteristics of NIH funded
policy D&I research projects, the current study provides
Table 3 NIH-funded policy D&I research projects by individual project details, federal fiscal years 2007–2014 (N = 12)
Project
number
Title Objective Funding
source
Start date Country
of focus
R01HL086450 An intervention for
promoting smoke-free policy
in rural Kentucky
To test the effects of a community intervention on
smoke-free policy outcomes in rural underserved
communities
NHLBI April 1, 2007 US
R01CA124404 Cancer control dissemination
research among state-level
policy makers
To increase the dissemination of evidence-based
interventions to control cancer, primarily focusing
on the uptake of effective environmental and policy
approaches among state-level policy makers
NCI September 27, 2007 US
R01MH072961 Mixed methods study of EBP
sustainment in a statewide
service system
To examine factors that either support or limit sustainment
of an evidence-based child neglect intervention in a large
statewide public service system
NIMH September 22, 2005 US
R01CA160327 Disseminating evidence-
based interventions to control
cancer
To increase the dissemination of EBPPs to control cancer,
focusing on the uptake of effective approaches among
state-level practitioners
NCI/OD May 3, 2012 US
R01DA030431 To test a payer/treatment
agency intervention to
increase use of
buprenorphine
To test whether clinician training and the use of
organizational change strategies are sufficient for
disseminating an evidence-based practice (EBP),
or if changes to both organizational systems and
payer policy result in greater EBP use
NIDA March 1, 2012 US
R03CA128644 Translating science into
policy: a survey of state
tobacco control plans
To examine the structures and processes used by
states to develop strategic plans to reduce tobacco
use and prevent initiation
NCI June 2, 2008 US
R21CA136435 Workplace health promotion To enhance the dissemination potential of a
successful intervention, Workplace Solutions
that was developed to disseminate a set of
15 evidence - based cancer prevention strategies
to workplaces
NCI July 16, 2009 US
R01MH104200 Value-based purchasing in
implementation of
depression care in
community clinics
To assess the role of value-based purchasing (VBP),
a policy strategy, to enhance planned implementation
of evidence-based care in CHCs
NIMH August 1, 2014 US
R01CA175329 Implementing tobacco use
treatment guidelines in
community health centers in
Vietnam
To fill the current research-to-practice gap by conducting a
randomized controlled trial that compares the
effectiveness and cost effectiveness of two practical
and highly replicable strategies for implementing
evidence-based guidelines for the treatment of
tobacco use in public health clinics in Vietnam
NCI September 30, 2013 Vietnam
R21MH098124 Development and validation
of implementation climate
measures
To develop measures of organizational climate, leadership,
and provider behaviors likely to impact the
implementation of evidence-based practices
NIMH June 24, 2013 US
R21CA172938 A retail policy laboratory:
modeling impact of retailer
reduction on tobacco use
To examine the interplay between retailer density
reductions and patterns of tobacco purchasing
NCI July 1, 2013 US
R21AI095979 Sustainable financial
incentives to improve
prescription practices for
malaria
To test an innovative, sustainable financial incentive
designed to reduce the number of non-malarial fevers that
are treated inappropriately with antimalarial drugs
NIAID April 1, 2012 Kenya
US United States, NIH National Institutes of Health, NCI National Cancer Institute, NIMH National Institute of Mental Health, NIDA National Institute on Drug Abuse,
NHLBI National Heart, Lung, and Blood Institute, OD NIH Office of the Director, NIAID National Institute of Allergy and Infectious Diseases, D&I dissemination and implementation
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investigators with guidance on approaches to policy D&I
research that they can consider when conceptualizing
research ideas and developing NIH proposals in this area.
Additional file
Additional file 1: NIH-funded policy D&I projects. (XLSM 583 kb)
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